Atlas Trials

Trial to Evaluate the Immunogenicity and Safety of the Co-administration of Live Attenuated Dengue and Chikungunya Vaccines Compared to Separate Administration in Adults Aged 18 to 59 Years.

Clinical trial NCT06973772 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06973772
Sponsor
Butantan Institute
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
DengueChikungunya
Start date
2027-03-31
Primary completion
2027-07-01
Enrollment
900

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.